Impact of Adverse Events on the Progression-Free Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study
Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-020-00179-7
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 11, 2020
Authors
Publisher
Springer Science and Business Media LLC